Notably, although MxA showed reduced sensitivity for diagnosing viral infections in LRTI patients, its diagnostic utility may have been underestimated, as many of these patients had longer symptom durations prior to enrolment and were possibly in the recovery phase. Here, MX1 is linked to viral infectious disease.